Nilam Holmes Limited 10671304 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is provision of beauty and health treatments. Digita Accounts Production Advanced 6.30.9574.0 true true 10671304 2024-04-01 2025-03-31 10671304 2025-03-31 10671304 bus:OrdinaryShareClass1 2025-03-31 10671304 core:CurrentFinancialInstruments 2025-03-31 10671304 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 10671304 core:Non-currentFinancialInstruments 2025-03-31 10671304 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 10671304 core:Goodwill 2025-03-31 10671304 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 10671304 core:FurnitureFittingsToolsEquipment 2025-03-31 10671304 core:LandBuildings 2025-03-31 10671304 core:OtherPropertyPlantEquipment 2025-03-31 10671304 bus:SmallEntities 2024-04-01 2025-03-31 10671304 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10671304 bus:FilletedAccounts 2024-04-01 2025-03-31 10671304 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10671304 bus:RegisteredOffice 2024-04-01 2025-03-31 10671304 bus:Director1 2024-04-01 2025-03-31 10671304 bus:Director2 2024-04-01 2025-03-31 10671304 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10671304 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10671304 core:Goodwill 2024-04-01 2025-03-31 10671304 core:PatentsTrademarksLicencesConcessionsSimilar 2024-04-01 2025-03-31 10671304 core:ComputerEquipment 2024-04-01 2025-03-31 10671304 core:FurnitureFittings 2024-04-01 2025-03-31 10671304 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 10671304 core:LandBuildings 2024-04-01 2025-03-31 10671304 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 10671304 countries:England 2024-04-01 2025-03-31 10671304 2024-03-31 10671304 core:Goodwill 2024-03-31 10671304 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 10671304 core:FurnitureFittingsToolsEquipment 2024-03-31 10671304 core:LandBuildings 2024-03-31 10671304 core:OtherPropertyPlantEquipment 2024-03-31 10671304 2023-04-01 2024-03-31 10671304 2024-03-31 10671304 bus:OrdinaryShareClass1 2024-03-31 10671304 core:CurrentFinancialInstruments 2024-03-31 10671304 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10671304 core:Non-currentFinancialInstruments 2024-03-31 10671304 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 10671304 core:Goodwill 2024-03-31 10671304 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 10671304 core:FurnitureFittingsToolsEquipment 2024-03-31 10671304 core:LandBuildings 2024-03-31 10671304 core:OtherPropertyPlantEquipment 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10671304

Nilam Holmes Limited
trading as Dermaspa
Unaudited Filleted Financial Statements
for the Year Ended 31 March 2025

Nilam Holmes Limited
trading as Dermaspa

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 11

Nilam Holmes Limited
trading as Dermaspa

Company Information

Directors | Mr P J Holmes Mrs N Holmes

Registered office | Unit K, Haybrook Barn Newport Road Broughton Milton Keynes, Buckinghamshire MK16 0HU

Nilam Holmes Limited
trading as Dermaspa

(Registration number: 10671304)
Balance Sheet as at 31 March 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | 287 | 863
Tangible assets | 5 | 199,074 | 175,852
|  | 199,361 | 176,715
Current assets |  |  |
Stocks | 6 | 15,000 | 15,000
Debtors | 7 | 84,800 | 72,913
Cash at bank and in hand |  | 117,818 | 51,403
|  | 217,618 | 139,316
Creditors: Amounts falling due within one year | 8 | (362,584) | (266,895)
Net current liabilities |  | (144,966) | (127,579)
Total assets less current liabilities |  | 54,395 | 49,136
Creditors: Amounts falling due after more than one year | 8 | (12,332) | (22,338)
Provisions for liabilities |  | (41,032) | (25,498)
Net assets |  | 1,031 | 1,300
Capital and reserves |  |  |
Called up share capital | 9 | 100 | 100
Retained earnings |  | 931 | 1,200
Shareholders' funds |  | 1,031 | 1,300

Nilam Holmes Limited
trading as Dermaspa

(Registration number: 10671304)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 October 2025 and signed on its behalf by:

......................................... Mr P J Holmes Director

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit K, Haybrook Barn
Newport Road
Broughton
Milton Keynes,
Buckinghamshire
MK16 0HU
England

These financial statements were authorised for issue by the Board on 3 October 2025.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Summary of disclosure exemptions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Going concern

The financial statements have been prepared on a going concern basis.

Exemption from preparing group accounts

The company has taken advantage of the exemption in section 398 of the Companies Act 2006 from the requirement to prepare consolidated financial statements, on the grounds that it is a small sized group.

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 20% reducing balance
Fixtures and fittings | 20% reducing balance
Leasehold improvements | 10% straight line
Computer and office equipment | 33% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.
Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.
Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | Straight line over 5 years
Patents | Straight line over 10 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised at the transaction price.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2024 - 12).

4 | Intangible assets

| Goodwill £ | Trademarks, patents and licenses £ | Total £
Cost or valuation
At 1 April 2024 | 1 | 862 | 863
At 31 March 2025 | 1 | 862 | 863
Amortisation
Amortisation charge | - | 576 | 576
At 31 March 2025 | - | 576 | 576
Carrying amount
At 31 March 2025 | 1 | 286 | 287
At 31 March 2024 | 1 | 862 | 863

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

5 | Tangible assets

| Land and buildings £ | Furniture, fittings and equipment £ | Other tangible assets £ | Total £
Cost or valuation
At 1 April 2024 | 11,074 | 40,004 | 352,688 | 403,766
Additions | - | 2,109 | 60,594 | 62,703
At 31 March 2025 | 11,074 | 42,113 | 413,282 | 466,469
Depreciation
At 1 April 2024 | 7,443 | 27,855 | 192,616 | 227,914
Charge for the year | 1,108 | 2,862 | 35,511 | 39,481
At 31 March 2025 | 8,551 | 30,717 | 228,127 | 267,395
Carrying amount
At 31 March 2025 | 2,523 | 11,396 | 185,155 | 199,074
At 31 March 2024 | 3,631 | 12,149 | 160,072 | 175,852

Included within the net book value of land and buildings above is £2,523 (2024 - £3,630) in respect of short leasehold land and buildings.

6 | Stocks

| 2025 £ | 2024 £
Other inventories | 15,000 | 15,000

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7 | Debtors

Current | Note | 2025 £ | 2024 £
Trade debtors |  | 55,746 | 52,839
Amounts owed by related parties |  | 9,556 | 6,268
Prepayments |  | 7,994 | 3,816
Other debtors |  | 11,504 | 9,990
|  | 84,800 | 72,913

8 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 10 | 9,999 | 10,000
Trade creditors |  | 72,344 | 105,752
Amounts owed to group undertakings and undertakings in which the company has a participating interest |  | 164,416 | 91,611
Taxation and social security |  | 91,273 | 63,508
Accruals and deferred income |  | 2,525 | 2,175
Other creditors |  | 22,027 | (6,151)
|  | 362,584 | 266,895

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 10 | 12,332 | 22,338

Nilam Holmes Limited
trading as Dermaspa

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

9 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £1 each | 100 | 100 | 100 | 100

10 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 2,332 | 12,338
Other borrowings | 10,000 | 10,000
| 12,332 | 22,338

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 9,999 | 10,000